The United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) advised people with a history of "significant" allergic reactions not to get the COVID-19 vaccine developed by Pfizer and BioNTech after two people had allergic reactions to the jab this week, APA reports citing Teletrader.
"As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday. Both are recovering well," Professor Stephen Powis, national medical director for the NHS in England, said.
Pfizer noted that the advisory was a precautionary measure and insisted its vaccine was "well tolerated with no serious safety concerns" reported during trials. MHRA chief executive, Dr June Raine, noted the UK is aware that "this wasn't a feature" in trials but decided to issue the advice and investigate the issue further as a precaution.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
